Welcome to our dedicated page for ALBEMARLE SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Albemarle Corporation filings document operating results, material events, governance matters, shareholder voting items, and capital-structure disclosures for a public specialty chemicals and critical materials company. Form 8-K reports cover quarterly financial results, credit agreement amendments, debt-related actions, board appointments, officer transitions, and completed portfolio transactions.
Proxy materials describe director elections, committee governance, executive compensation, shareholder proposals, and voting procedures. Albemarle's filing record also documents the completed disposition of a controlling stake in Ketjen, retained ownership interests, integration of Performance Catalyst Solutions, and financing arrangements tied to the company's global lithium, bromine and specialty product businesses.
ALBEMARLE CORP (ALB) reported that Max Hood, its Chief Accounting Officer, has filed an initial ownership report on Form 3 as an officer of the company. The filing lists no reportable transactions in ALB securities and notes an Exhibit 24 Power of Attorney authorizing execution of the filing.
ALBEMARLE CORP (ALB) reported that its Board of Directors appointed Max W. Hood as Chief Accounting Officer, effective August 24, 2026. Upon appointment he will serve as the company’s principal accounting officer.
Hood, age 47, previously served as co-Chief Financial Officer of The ODP Corporation, after earlier roles there as Chief Accounting Officer and Controller and in accounting and treasury. His compensation includes a $400,000 annual base salary, a 2026 target bonus equal to 50% of eligible earnings (prorated for 2026), participation in a long-term incentive plan with a target value of 70% of base salary, and a sign-on grant of restricted stock units valued at $200,000 that vest in three equal annual installments. The company states there are no family relationships, related-party transactions, or special arrangements connected to his appointment.
Albemarle Corporation reported net sales of $1.74 billion for the quarter ended June 30, 2026 and net income attributable to the company of $479.9 million, compared with $1.33 billion and $22.9 million a year earlier. Diluted earnings per share attributable to common shareholders were $3.52 versus a loss of $0.16.
For the first half of 2026, net sales were $3.17 billion and net income attributable to the company was $799.1 million, with diluted EPS of $5.87. Operating cash flow rose to $1.06 billion, supporting a reduction of total long‑term debt to $1.88 billion from $3.19 billion at year‑end 2025. The sale of the Refining Solutions business generated $525.2 million of cash and a pre‑tax loss of $95.0 million, while the sale of the 50% Eurecat S.A. stake produced a $42.3 million gain. Energy Storage segment adjusted EBITDA increased to $723.5 million in the quarter, and the Windfield joint venture contributed equity income of $151.6 million in Q2. Albemarle also recorded $33.2 million of restructuring and asset write‑off charges year‑to‑date and expects an additional $70–$90 million of Kemerton Train 1 restructuring costs through 2027. The quarterly common dividend was raised to $0.41 per share beginning with the October 1, 2026 payment.
Albemarle Corporation reported strong second-quarter 2026 results, with net sales of $1.74 billion and net income attributable to the company of $480 million, as higher lithium pricing and growth in Specialties drove performance. Net sales rose 31% from $1.33 billion, while adjusted EBITDA increased 155% to $858 million and adjusted diluted EPS reached $3.75.
The Energy Storage segment generated net sales of $1.28 billion, up 78%, with adjusted EBITDA of $723 million, up 229%, supported by an 11% volume increase to 65 kT LCE and a 60% rise in average realized lithium price to $19.53/kg LCE. Specialties delivered net sales of $423 million, up 20%, and adjusted EBITDA of $118 million, up 61%, helped by higher bromine volumes and pricing and productivity gains.
Operating cash flow in the quarter was $710 million and free cash flow $638 million; first-half 2026 operating cash flow reached $1.06 billion. As of June 30, 2026, Albemarle had about $3.2 billion of liquidity and a net debt to adjusted EBITDA ratio of 0.5. Management outlined 2026 scenarios tied to lithium prices, with total net sales of $4.1–$7.8 billion and adjusted EBITDA of $0.9–$4.4 billion, raised its Specialties outlook, and reduced expected 2026 capital expenditures to roughly $500 million.
DESALLES BARTOLOMEO EDUARDO reported acquisition or exercise transactions in this Form 4 filing.
Albemarle Corporation director Desalles Bartolomeo Eduardo received a grant of 1,375 shares of common stock as non-employee director compensation. The pro rata award, made under the Albemarle Corporation 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, was granted on July 21, 2026 and is scheduled to vest on July 1, 2027. Following this award, he directly holds 1,375 common shares.
Albemarle Corp director DeSalles Bartolomeo Eduardo has filed an initial Form 3 as a reporting person in the capacity of director only, not as an officer or 10% owner. The report shows no equity transactions or derivative positions and references an Exhibit 24 power of attorney authorization.
Albemarle Corporation appointed Eduardo De Salles Bartolomeo as an independent member of its Board of Directors, effective July 21, 2026. He joins the Board’s Audit and Finance Committee and Safety, Sustainability, Operations & Capital Committee.
Under the non-employee director compensation program, Bartolomeo will receive a $120,000 annual cash retainer and an annual restricted stock grant valued at $170,000, both pro-rated for his partial year of service in 2026, with the stock amount rounded up to the nearest 25 shares. Albemarle highlights his more than 30 years of leadership in global mining and logistics, including service as Chief Executive Officer of Vale S.A. from 2019 to 2024 and other senior roles in metals and logistics businesses, as well as his current board role at Boston Metal, Inc.
ALBEMARLE CORP director Glenda J. Minor received a grant of 1,250 Phantom Stock units tied to common shares. The award represents non-employee director stock compensation under the 2023 Directors Plan and converts into common stock on a 1-for-1 basis.
The units are scheduled to vest on July 1, 2027 and are payable as shares of common stock upon events she establishes under the plan’s terms. Following this grant, Minor holds a total of 5,606 Phantom Stock units, which also accrue dividend equivalent rights and have no expiration date.
Collins Michelle T reported acquisition or exercise transactions in this Form 4 filing.
ALBEMARLE CORP director Michelle T. Collins reported stock-based compensation grants, not open-market trades. On July 1, 2026 she received 1,250 shares of common stock as an annual non-employee director award under the 2023 Directors Plan, scheduled to vest on July 1, 2027. She also received 2 additional shares representing dividends accrued on a prior award granted on February 26, 2026 that fully vested on July 1, 2026.
Albemarle Corporation director Ralf Hans Cramer reported routine equity compensation and related tax withholding in company stock. On July 1, 2026, he received an annual non-employee director stock award and additional shares from dividends settled in stock under the 2023 Directors Plan. On the same date, a portion of shares from these vesting awards and dividend equivalents was withheld at $136.08 per share to cover associated tax liabilities, rather than sold in the open market. The transactions reflect compensation and tax mechanics, not discretionary buying or selling of Albemarle shares.